| Date |
Title |
Link to PDF file |
| June 20, 2011 |
Anaphore Appoints Paul A. Grayson President and CEO |
|
| May 18, 2011 |
Anaphore Appoints Michael F. Haller, Ph.D.,
Senior Vice President of Strategic Partnerships and
H Casey Logan Senior Vice President of Business Development |
|
| May 17, 2011 |
Anaphore to Present Company Overview with Focus on Atrimer Technology Platform at 13th Annual C21 BioVentures Conference |
|
| Dec 13, 2010 |
Anaphore Enters R&D Partnership with Mitsubishi Tanabe Pharma
To Develop and Commercialize Novel Protein Pharmaceuticals For Autoimmune Disorders |
|
| June 10, 2010 |
Anaphore Names Former GSK Top Executive Dr. Russell G. Greig as Executive Chairman to Assist in Driving Anaphore's Pipeline of Next Generation Biological Therapies |
|
| May 14, 2009 |
Anaphore Announces $13 Million Second Closing to Series A Financing |
|
| January 7, 2009 |
Anaphore Announces $25 Million Series A Financing |
|
| April 15, 2008 |
Anaphore Receives $8 Million In Financing |
|
